Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma

BACKGROUND: Although immunotherapy has shown clinical activity in lung adenocarcinoma (LUAD), LUAD prognosis has been a perplexing problem. We aimed to construct an immune-related lncRNA pairs (IRLPs) score for LUAD and identify what immunosuppressor are appropriate for which group of people with LU...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Jinman, Chen, Zhongwu, Chen, Zishan, Chen, Jin, Liu, Maolin, Xu, Xinying, Liu, Yuhang, Yang, Shuyan, Hu, Zhijian, He, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101821/
https://www.ncbi.nlm.nih.gov/pubmed/35562727
http://dx.doi.org/10.1186/s12931-022-02043-4

Ejemplares similares

Ejemplares similares